Informatie:
Fout:
ID
28270
Beschrijving
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Study part: Prior + concomitant diseases. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Trefwoorden
Versies (2)
- 07-12-17 07-12-17 -
- 01-01-18 01-01-18 -
Houder van rechten
Prof. Dr. med. Georg Heß
Geüploaded op
1 januari 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Diseases GOAL Trial B-cell Lymphoma NCT02499003
Diseases GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Diseases GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Subject ID
Item
Subject-ID
text
C2348585 (UMLS CUI [1])
medical conditions
Item
Are there any relevant medical conditions?
boolean
C0012634 (UMLS CUI [1])
Disease number
Item
No.
integer
C0750480 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
specification
Item
Disease, specify term:
text
C2348235 (UMLS CUI [1])
Start date
Item
Start date
date
C0808070 (UMLS CUI [1])
Stop date
Item
Stop date
date
C0806020 (UMLS CUI [1])
Ongoing disease End of Treatment
Item
Ongoing at End of Treatment?
boolean
C0549178 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0580352 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,2])
C0580352 (UMLS CUI [1,3])
Geen commentaren